Billable Medical Code for Primary Hypercoagulable State
Diagnosis Code for Reimbursement Claim: ICD-9-CM 289.81
Code will be replaced by October 2015 and relabeled as ICD-10-CM 289.81.
The Short Description Is: Prim hypercoagulable st.
Known As
Factor V leiden is also known as activated Protein C resistance, anticardiolipin syndrome, antiphospholipid syndrome, antiphospholipid syndrome complication in pregnancy, antiphospholipid syndrome in pregnancy, antiphospholipid syndrome postpartum, antithrombin 3 deficiency, antithrombin III deficiency, factor 5 Leiden mutation, factor 5 Leiden mutation heterozygous, factor 5 Leiden mutation homozygous, factor V Leiden mutation, factor V Leiden mutation heterozygous, factor V Leiden mutation homozygous, hereditary antithrombin III deficiency, hereditary heparin cofactor II deficiency, hereditary protein C deficiency, hereditary protein S deficiency, hereditary thrombophilia, heterozygous Factor V Leiden mutation, heterozygous protein C deficiency, heterozygous protein S deficiency, heterozygous prothrombin G20210A mutation, homozygous Factor V Leiden mutation, homozygous protein C deficiency, homozygous protein S deficiency,
homozygous prothrombin G20210A mutation, hypercoagulability state, hypercoagulable state, hypercoagulable state (tendency to form clots), hypercoagulable state primary, lupus anticoagulant,
lupus anticoagulant disorder, postpartum (after childbirth) antiphospholipid syndrome, postpartum antiphospholipid syndrome, protein C deficiency disease, protein C deficiency disorder, protein C resistance, protein S deficiency disease, protein S deficiency disorder, prothrombin G20210A mutation, prothrombin gene mutation, resistance to activated protein C due to Factor V Leiden, thrombophilia due to acquired antithrombin III deficiency, thrombophilia due to acquired protein C deficiency, thrombophilia due to acquired protein S deficiency, thrombophilia due to antiphospholipid antibody, and upper gastrointestinal hemorrhage associated with hypercoagulability state. This excludes anti-phospholipid antibody finding without diagnosis (795.79), anti-phospholipid antibody with hemorrhagic disorder (286.53), lupus anticoagulant (LAC) finding without diagnosis (795.79), lupus anticoagulant (LAC) with hemorrhagic disorder (286.53), secondary activated protein C resistance (289.82), secondary antiphospholipid antibody syndrome (289.82), secondary lupus anticoagulant with hypercoagulable state (289.82), secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (289.82), systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (795.79), and systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (286.53). This applies to activated protein C resistance, antiphospholipid antibody syndrome, antithrombin III deficiency, factor V Leiden mutation, lupus anticoagulant with hypercoagulable state, protein C deficiency, protein S deficiency, prothrombin gene mutation, and systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state.
Factor V Leiden Definition and Symptoms
Factor V leiden is a mutation in the clotting factor V in the blood. This mutation greatly increases a persons chance of developing blood clots in veins. Men and women are equally affected by this mutation. Most people show no symptoms or signs however in some cases a person may develop a clot in one of their veins that is an indication of this blood disorder.